Sichuan Kelun-Biotech (6990)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 27 Oct 2026
Key indicators
| Last close | HKD 453.20 |
|---|---|
| 52-week range | 339.60 – 562.50 |
| Return, 1 month / 3 months | −3.0% / −11.7% |
| Return, 1 year / 3 years | +5.5% / +489.0% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 51.6% |
| Worst drawdown (1 year) | -28.8% |
| Average daily value traded | 311.12M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sichuan Kelun-Biotech is a biopharmaceutical company based in China that researches, develops and commercialises medicines. Its work centres on innovative treatments in areas such as oncology and other serious diseases, including antibody-drug conjugates and small-molecule drugs. The company serves patients and healthcare providers through its own product portfolio and through partnerships with pharmaceutical companies that license its drug candidates for development and sale in markets outside China.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 6990, and the price on this page is in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sichuan Kelun-Biotech (6990) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 453.20 on 27 October 2026.
Its price-based Market X-Ray is 74 out of 100 (a strong price profile), ranking 233 of 2,619 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.5% and over the last three months it fell 11.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | -1.1% | ||
| From 52-week high | -16.5% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -11.7% | ||
| 6-month return | -2.9% | ||
| 12-month return, skipping the last month | 8.7% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 51.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -28.8% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 311.12M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.2% |
|---|---|
| 1 month | −3.0% |
| 3 months | −11.7% |
| 6 months | −2.9% |
| 1 year | +5.5% |
| 3 years | +489.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 481.28 / 458.26 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 26.82 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.